EP4003400
DOSING FOR PREVENTION OR TREATMENT OF GRAFT VERSUS HOST DISEASE (GVHD) WITH IL-22 FC FUSION PROTEINS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
24.7.2020EP published:
3.4.2024EP application number:
20757034.2
EPO information:
European Patent Register
Max expiry date:
23.7.2040
Title in English:
DOSING FOR PREVENTION OR TREATMENT OF GRAFT VERSUS HOST DISEASE (GVHD) WITH IL-22 FC FUSION PROTEINSLanguage of the patent:
English
Timeline
Today
24.7.2020EP application
3.4.2024EP Publication
Owner
Name:
F. Hoffmann-La Roche AGAddress:
Grenzacherstrasse 124, 4070 Basel, CH
Inventor
Name:
KALO, MatthewAddress:
South San Francisco, CA 94080-4990, US
Name:
LU, Timothy Then-ChiohAddress:
South San Francisco, CA 94080-4990, US
Name:
PECK, Melicent ClareAddress:
South San Francisco, CA 94080-4990, US
Name:
SUKUMARAN, SiddharthAddress:
South San Francisco, CA 94080-4990, US
Name:
WANG, YehongAddress:
South San Francisco, CA 94080-4990, US
Name:
WONG, Chin YatAddress:
South San Francisco, CA 94080-4990, US
Name:
DAY, Peter WilliamAddress:
South San Francisco, CA 94080-4990, US
Priority
Number:
201962879306 PDate:
26.7.2019Country:
US
Number:
202062976321 PDate:
13.2.2020Country:
US
Classification
Categories:
A61K 38/20, A61P 37/06, C07K 14/54, C07K 19/00